Cipla Ltd, announced on Friday (June 21) that its manufacturing facility in Goa, India, underwent an inspection by the US…
Browsing: FORM 483
Lupin announced that the United States Food and Drug Administration (USFDA) has completed its inspection of the company’s injectable facility…
Torrent Pharma, has announced that its manufacturing facility in Indrad, Gujarat, has received a Form 483 with five observations from…
Dr Reddy’s Laboratories Ltd, a prominent pharmaceutical company based in Hyderabad, announced on Friday that the United States Food &…
Lupin Limited has announced that the US Food and Drug Administration (FDA) concluded a pre-approval inspection of its manufacturing facility…
Pharmaceutical giant Cipla Ltd disclosed on Wednesday that it has received one inspectional observation in Form 483 from the US…